Approval · Notice of Compliance 3909 · 1997
LEVAQUIN: Notice of Compliance 3909
Issued November 14, 1997
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 3909
- Date
- November 14, 1997
- Company
- Janssen-Ortho Inc.
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
- Therapeutic class
- Antibacterial agent
Products in this notice
Medicinal ingredients
- LEVOFLOXACIN 5 MG per ML
- LEVOFLOXACIN 25 MG per ML
- LEVOFLOXACIN 250 MG per TAB
- LEVOFLOXACIN 500 MG per TAB